<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01798225</url>
  </required_header>
  <id_info>
    <org_study_id>P20RR017696-06</org_study_id>
    <secondary_id>P20RR017696</secondary_id>
    <nct_id>NCT01798225</nct_id>
  </id_info>
  <brief_title>Relationship of Periodontal Disease Treatment and Type 2 Diabetes Mellitus in the Gullah Population</brief_title>
  <official_title>The Relationships Between Periodontal Disease and Type 2 Diabetes Mellitus in the Gullah Population and the Effects of Mechanical Periodontal Therapy and Systemic Antibiotics on the Glycemic Control</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of South Carolina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Center for Research Resources (NCRR)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical University of South Carolina</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Our overall hypothesis is that treatment of periodontal disease will produce better diabetes
      glycemic control (glycated hemoglobin A1c, or HbA1c) and reduced levels of the catalytically
      active form of matrix metalloproteinase (aMMP-8) in the Gullah African American type 2
      diabetes patients living on the Sea Islands of the South Carolina coast. The gingival
      crevicular fluid (GCF) aMMP-8 levels will be measured through a site-specific, novel
      noninvasive technique allowing the pathophysiological status of the periodontium tissue to be
      monitored. The investigators will conduct an interventional study on this population with
      minimal genetic admixture.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Specific Aim 1: To ascertain the rate of periodontal disease progression on poorly controlled
      Type 2 diabetic Gullah African American patients as compared to well-controlled Gullah
      African American patients. The host inflammatory response appears to be the critical
      determinant for susceptibility and severity of marginal periodontitis especially in
      systemically compromised individuals13, with diabetic status perhaps increasing host
      susceptibility to periodontal infection due to impaired immune response14. Patients have been
      evaluated 6 months to one year prior to periodontal therapy (this evaluation is connected to
      a previous COBRE project entitled &quot;Epidemiological Study of Periodontal Disease and Diabetes&quot;
      by Dr. J. Fernandes). A reevaluation will be made at the time of periodontal therapy.
      Clinical periodontal parameters and HbA1c levels will be compared.

      Specific Aim 2: To assess the effects of successful periodontal therapy on the level of
      glycemic control in this Gullah African American population. Authors addressing whether the
      treatment of periodontitis or other infections of the oral cavity can improve glycemic
      control in diabetic patients report contradictory results. We will treat periodontal patients
      with mechanical therapy (scaling and root planning) and oral hygiene instruction, with or
      without systemic antibiotic administration (Table 1). The HbA1c, fasting glucose and clinical
      periodontal parameters will be evaluated prior to the periodontal intervention, and at 3 and
      6 months after therapy. We plan to continue to recruit, enroll and assess new patients from
      the Gullah African American community living on the Sea Islands of the South Carolina coast
      for future research projects

      Specific Aim 3: To assess the concentration of the catalytically active form of MMP-8 at
      baseline (prior to periodontal intervention) and at 3 and 6 months later. Polymorphonuclear
      (PMN) leukocyte-derived MMP-8 is predominantly present in periodontitis-affected GCF9,15-16.
      Analysis of GCF for aMMP-8 could provide a novel useful noninvasive technique to assess and
      monitor the pathophysiological status of the periodontium tissue in a site-specific
      manner9-10.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2007</start_date>
  <completion_date type="Actual">January 2010</completion_date>
  <primary_completion_date type="Actual">January 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Glycated Hemoglobin A1c</measure>
    <time_frame>Change between baseline to 6-month post-treatment</time_frame>
    <description>Glycated Hemoglobin A1c</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Periodontal Pocket Probing Depth (PD)</measure>
    <time_frame>Change between baseline to 6-month post-treatment</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">113</enrollment>
  <condition>Periodontal Disease</condition>
  <condition>Type 2 Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants received mechanical periodontal therapy, oral hygiene instructions and placebo (antibiotic) pills.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Doxycycline</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants received mechanical periodontal therapy, oral hygiene instructions and antibiotic (Doxycycline 100mg x 14 pills)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Participants received mechanical periodontal therapy, oral hygiene instructions and placebo pills.</description>
    <arm_group_label>Control</arm_group_label>
    <other_name>Control Group</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Doxycycline</intervention_name>
    <description>Participants received mechanical periodontal therapy, oral hygiene instructions and Doxycycline 100mg x 14 pills (to be taken one a day for 14 days)</description>
    <arm_group_label>Doxycycline</arm_group_label>
    <other_name>Intervention Group</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Gullah African Americans;

          -  With type 2 diabetes mellitus defined according to the American Diabetes Association
             criteria;

        Other inclusion criteria are presented under each Specific Aim:

          -  AIM 1: Participants who have received oral, dental, periodontal, diabetes and genotype
             assessment through enrollment in Dr. J. Fernandes' COBRE project.

          -  AIM 2 and 3: Participants with severe chronic periodontitis, as defined by at least
             one tooth surface with probing depth (PD)≥5mm.

        Exclusion Criteria:

          -  Severe concurrent illnesses / conditions that would limit their daily life or require
             extensive systemic treatment, such as malignancy, severe cardiovascular disease, organ
             transplant, or inadequate understanding due to mental disorders;

          -  Finger stick blood glucose measurement of more than 350mg/dl or less than 70mg/dl
             after second measurement;

          -  Systolic blood pressure of more than 180mm Hg or diastolic pressure of more than 100mm
             Hg;

          -  Fasting serum C-peptide &lt; 1ng/ml (documentation or test);

          -  Serum creatinine ≥ 1.6mg/dl;

          -  Abnormal hepatic function;

          -  Hemoglobinopathy (sickle cell trait/hemolytic anemia) interfering with HbA1c
             monitoring;

          -  Other underlying illness/conditions which, in the doctor's judgment, may prevent
             patient from adherence to the study protocol;

          -  Unwillingness to sign the informed consent form or enter the study;

          -  Pregnant women;

          -  Patients in need of antibiotic prophylaxis prior to dental procedures or patients that
             have been treated with any kind of antibiotics in the past 3 months.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Renata S. Leite</last_name>
    <role>Study Director</role>
    <affiliation>Medical University of South Carolina</affiliation>
  </overall_official>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>April 18, 2012</study_first_submitted>
  <study_first_submitted_qc>February 21, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 25, 2013</study_first_posted>
  <results_first_submitted>May 4, 2017</results_first_submitted>
  <results_first_submitted_qc>October 3, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">October 4, 2018</results_first_posted>
  <last_update_submitted>October 3, 2018</last_update_submitted>
  <last_update_submitted_qc>October 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Periodontal Disease</keyword>
  <keyword>Type 2 Diabetes Mellitus</keyword>
  <keyword>Gullah African Americans</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontal Diseases</mesh_term>
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Doxycycline</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruitment period from 12/18/2007 to 01/12/2010. Recruitment happened from previous studies and community events.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Control</title>
          <description>Participants received mechanical periodontal therapy, oral hygiene instructions and placebo (antibiotic) pills.
Placebo: Participants received mechanical periodontal therapy, oral hygiene instructions and placebo pills.</description>
        </group>
        <group group_id="P2">
          <title>Doxycycline</title>
          <description>Participants received mechanical periodontal therapy, oral hygiene instructions and antibiotic (Doxycycline 100mg x 14 pills)
Doxycycline: Participants received mechanical periodontal therapy, oral hygiene instructions and Doxycycline 100mg x 14 pills (to be taken one a day for 14 days)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="57"/>
                <participants group_id="P2" count="56"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="57"/>
                <participants group_id="P2" count="53"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Control</title>
          <description>Participants received mechanical periodontal therapy, oral hygiene instructions and placebo (antibiotic) pills.
Placebo: Participants received mechanical periodontal therapy, oral hygiene instructions and placebo pills.</description>
        </group>
        <group group_id="B2">
          <title>Doxycycline</title>
          <description>Participants received mechanical periodontal therapy, oral hygiene instructions and antibiotic (Doxycycline 100mg x 14 pills)
Doxycycline: Participants received mechanical periodontal therapy, oral hygiene instructions and Doxycycline 100mg x 14 pills (to be taken one a day for 14 days)</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="57"/>
            <count group_id="B2" value="56"/>
            <count group_id="B3" value="113"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="45"/>
                    <measurement group_id="B2" value="43"/>
                    <measurement group_id="B3" value="88"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="47"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="85"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="57"/>
                    <measurement group_id="B2" value="56"/>
                    <measurement group_id="B3" value="113"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="57"/>
                    <measurement group_id="B2" value="56"/>
                    <measurement group_id="B3" value="113"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="57"/>
                    <measurement group_id="B2" value="56"/>
                    <measurement group_id="B3" value="113"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Glycated Hemoglobin A1c</title>
        <description>Glycated Hemoglobin A1c</description>
        <time_frame>Change between baseline to 6-month post-treatment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>Participants received mechanical periodontal therapy, oral hygiene instructions and placebo (antibiotic) pills.
Placebo: Participants received mechanical periodontal therapy, oral hygiene instructions and placebo pills.</description>
          </group>
          <group group_id="O2">
            <title>Doxycycline</title>
            <description>Participants received mechanical periodontal therapy, oral hygiene instructions and antibiotic (Doxycycline 100mg x 14 pills)
Doxycycline: Participants received mechanical periodontal therapy, oral hygiene instructions and Doxycycline 100mg x 14 pills (to be taken one a day for 14 days)</description>
          </group>
        </group_list>
        <measure>
          <title>Glycated Hemoglobin A1c</title>
          <description>Glycated Hemoglobin A1c</description>
          <units>percentage of Glycated Hemoglobin A1c</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="57"/>
                <count group_id="O2" value="56"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8" lower_limit="5.3" upper_limit="12.8"/>
                    <measurement group_id="O2" value="8.2" lower_limit="4.7" upper_limit="14.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Periodontal Pocket Probing Depth (PD)</title>
        <time_frame>Change between baseline to 6-month post-treatment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>Participants received mechanical periodontal therapy, oral hygiene instructions and placebo (antibiotic) pills.
Placebo: Participants received mechanical periodontal therapy, oral hygiene instructions and placebo pills.</description>
          </group>
          <group group_id="O2">
            <title>Doxycycline</title>
            <description>Participants received mechanical periodontal therapy, oral hygiene instructions and antibiotic (Doxycycline 100mg x 14 pills)
Doxycycline: Participants received mechanical periodontal therapy, oral hygiene instructions and Doxycycline 100mg x 14 pills (to be taken one a day for 14 days)</description>
          </group>
        </group_list>
        <measure>
          <title>Periodontal Pocket Probing Depth (PD)</title>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="57"/>
                <count group_id="O2" value="56"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.98" spread="0.0001"/>
                    <measurement group_id="O2" value="-1.37" spread="0.0001"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Control</title>
          <description>Participants received mechanical periodontal therapy, oral hygiene instructions and placebo (antibiotic) pills.
Placebo: Participants received mechanical periodontal therapy, oral hygiene instructions and placebo pills.</description>
        </group>
        <group group_id="E2">
          <title>Doxycycline</title>
          <description>Participants received mechanical periodontal therapy, oral hygiene instructions and antibiotic (Doxycycline 100mg x 14 pills)
Doxycycline: Participants received mechanical periodontal therapy, oral hygiene instructions and Doxycycline 100mg x 14 pills (to be taken one a day for 14 days)</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="57"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="56"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="57"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="56"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="57"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="56"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Renata Leite</name_or_title>
      <organization>Medical University of South Carolina</organization>
      <phone>843-792-3908</phone>
      <email>leiter@musc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

